Martine Rothblatt and James Gardner answering questions during the Transvision Q&A
Martine Rothblatt started United Therapeutics (NASDAQ: UTHR) in 1996 and has served as Chairman & CEO since its inception. The company develops and/or commercializes unique analogs of natural molecules for cardio-pulmonary disorders, novel monoclonal antibodies for certain cancers, small glycobiologicals for infectious diseases, telemedical services (including for International Space Station astronauts) and nutriceuticals.
Prior to starting United Therapeutics, in 1990 Dr. Rothblatt created Sirius Satellite Radio and served as its first Chairman & CEO. She also initiated and led the effort to get the Federal Communications Commission to create the satellite radio service in which both Sirius and XM operate, based on underutilized frequencies and the novel concept of using GPS-type antennas for digital audio. Her publications include five books and over fifty peer-reviewed articles.


